In this study, we investigated the contribution of CD34+ cells to AAA development and progression using advanced techniques, including scRNA‐seq, dual recombinase‐mediated genetic lineage tracing, IF staining with 3D aortic reconstruction, and various gene‐modified mouse strains. The gene discussed is CD34; the disease is triple-A syndrome.